| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  NHS The NHS was launched in 1948. It was born out of a long-held ideal that good healthcare should be available to all, regardless of wealth – one of the NHS's core principles. With the exception of some charges, such as prescriptions, optical services and dental services, the NHS in England remains free at the point of use for all UK residents. This currently stands at more than 64.6 million people in the UK and 54.3 million people in England alone. The NHS in England deals with over 1 million patients every 36 hours. It covers everything, including antenatal screening, routine … Type: | 101 | 50 | 3 | 231,482 |
 | Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has a significant corporate presence in Palo Alto, CA and Philadelphia, PA … Type: | 13 | 3 | 1 | 3,385 |
 | American Chemical Society Improving all people’s lives through the transforming power of chemistry. The American Chemical Society is a congressionally chartered independent membership organization that represents professionals at all degree levels and in all fields of the chemical sciences. With more than 150,000 members, ACS is the world’s largest scientific society and one of the world’s leading sources of authoritative scientific information. A nonprofit organization, ACS is at the forefront of the evolving chemistry enterprise and the premier professional home for chemists, chemical engineers and related professions around the globe. ACS is dynamic and visionary, committed to “Improving all people’s lives through the … Type: | 49 | 10 | 40 | 2,336 |
 | Cambridge University Hospitals NHS Foundation Trust Make a difference in your next career move, come and join Cambridge University Hospitals. Cambridge University Hospitals (CUH) is one of the largest and best known Trusts in the country. As the local hospital for our community we deliver care through Addenbrooke’s and the Rosie hospitals offering general, specialist, women’s and maternity care respectively. We are a leading national centre for specialist treatment, a government-designated comprehensive biomedical research centre, one of only five academic health science centres in the UK and a university teaching hospital with a worldwide reputation. Building on these different elements, our vision is to improve people’s … Type: | 2 | 0 | 1 | 4,704 |
 | Neighborhood, VCLS Innovation Center We are a life science innovation center supporting healthtech entrepreneurs providing strategic mentorship for growth. Neighborhood is a life science innovation center. It pools regulatory expert resources with a focus on taking the risk away from development of the health technology products. Our mission is to accompany healthtech startups to their next significant valuation milestones. We provide guidance from the earliest stages to embrace regulations which can be a competitive advantage in product development. Type: | 4 | 1 | 1 | 5 |
 |  The French Tech Journal Covering the global community of French startups, entrepreneurs, VCs, and innovators. The French Tech Journal is a newsletter dedicated to covering the dynamic global ecosystem of French entrepreneurs and investors. Type: | 44 | 1 | 43 | 2 |
 | Tenexa [Automatic translation follows] Tenexa brings together the brands: Infodis, Atexweb, IT-Tude and Prolival Founded in 1985, Tenexa is a Digital Services Company (ESN). The Tenexa group is made up of several key subsidiaries, each specializing in specific market segments (Infodis IT, Atexweb, IT-Tude & Prolival) and is firmly positioned towards the future with a strong focus on Cloud services, cybersecurity, and global IT services outsourcing, covering from the DataCenter to the user, to meet the diverse needs of its customers as part of a strategy of continuous innovation. End users: Outsourcing Transition, Migration Deployments, Consulting and Software Integration: ITSM/ESM solutions … Type: | 11 | 3 | 11 | 482 |
 | Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: | 3 | 2 | 3 | 51 |
 |  Xerago B2B Building Predictable, Cost-Optimal Revenue Engines for B2B Enterprises At Xerago B2B, we empower mid-market and enterprise B2B companies to achieve sustainable growth through our unique approach to Digital Impact. Our comprehensive solutions span Consulting, Projects, and Digital as a Service, focusing on Data, Experiences, Technology, and Campaigns and Commerce. We help our clients optimize targeting, streamline operations, and enhance customer experiences, ensuring predictable revenue and long-term success. Join us in transforming digital initiatives into powerful engines for growth and customer satisfaction. Type: | 41 | 0 | 41 | 555 |
 | LimFlow Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI) LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations … Type: | 1 | 1 | 0 | 29 |
 | Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: | 4 | 1 | 1 | 114 |
 | Niryo Niryo is a French startup designing collaborative #robots for universities, engineering schools, R&D & training centers. Niryo is a French startup designing desktop collaborative #robots for universities, engineering schools, training centers and research centers. Its reality? Democratizing cobotics and allowing its accessibility, while promoting a new vision for industry tinted with reason, humanity, durability and resilience. To keep on materializing this ambition, a team of forty passionate develop cutting edge hardware and software. This way, professionals are free to automate, research and train without a hassle. Embeddable in a variety of ecosystems, Niryo's cobots promote the awareness of a world … Type: | 49 | 10 | 17 | 49 |
 | Invyo Europe's leading data platform for data-driven investors (Venture Capital / Private Equity / Family Office) Since 2018, INVYO has been the trusted partner for investors in private equity, venture capital and family offices. We are a reference platform in Europe, propelling investors towards a data and tech-driven investment model thanks to AI. Our sector expertise harnesses your data to boost your human and financial performance. - French publisher - More than 50 client funds - 16 data experts - 2 offices: Paris & Madrid - SaaS solutions Our mission : At INVYO, we unleash the potential of investment teams through … Type: | 79 | 6 | 74 | 21 |
 | Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 46 | 12 | 23 | 58 |
 | Interaction Healthcare [Automatic translation follows] Your strategy deserves the best treatment 100% digital agency specializing in the health sector. Founded in 2008, Interaction Healthcare's expertise is based on 4 pillars: - digital strategy consulting; - web and social media solutions; - mobile solutions and new interfaces; - digital medical simulation and serious game. Interaction Healthcare designs and develops digital communication and e-learning tools for the pharmaceutical industry, university hospitals, simulation centers, learned societies, patient associations, health professionals and the general public. Recognized as an innovative company by the Oséo Excellence 2012 network and a partner of INRIa, a digital research laboratory, the … Type: | 45 | 6 | 40 | 12 |
 | ELICIT PLANT The only efficient Bio-Intrant to fight Water Stress ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, … Tags: FrenchTech2030 Type: | 18 | 10 | 11 | 75 |
 | Mainstay Medical First and Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands. Type: | 1 | 0 | 1 | 143 |
 | Material Innovation Initiative Cultivating a global market for next-gen materials across the fashion, automotive, and home goods industries. The Material Innovation Initiative (MII) is a think tank focused on research, knowledge-sharing, and fostering connections to fast-track the development of environmentally preferable and animal-free materials. We work to cultivate a global market for next-gen materials across the fashion, automotive, and home goods industries. Subscribe to our newsletter: bit.ly/MIINews Annual Material Innovation Conference, Environmental Data Coalition, State of the Industry Report on Next-Gen Materials, Brand Engagement Report, Consumer Research, Science & Technology Assessment reports Type: | 7 | 0 | 6 | 13 |
 | Edison Group As a content-led IR business, Edison helps companies stand out and meet the right shareholders. Edison’s integrated investor relations solution combines expert analyst content, digital targeting, and active investor engagement. This drives liquidity and valuations by building bigger, better informed, and more engaged investor audiences globally. Edison has a proven history of increasing liquidity and valuations for its clients. Edison’s content can be viewed by all investors, anywhere in the world. Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). Research, Commercial Due Diligence, Institutional Investor, Investor Relations , Investment Research, Financial Services, Digital IR, Capital Markets, and … Type: | 25 | 1 | 23 | 105 |
 | IXO PRIVATE EQUITY [Automatic translation follows] iXO Private Equity. Invest, Invest, Succeed, Together iXO Private Equity is a management company that mainly carries out LBO and development capital transactions. Its team is made up of 19 people, including 14 professional investors with complementary experience. iXO Private Equity is one of the largest independent French players in small and mid-cap. The management company, based in Toulouse, now manages more than €610 million in assets and invests per project from €2 to €15 million in equity, primarily in companies in the greater South of France and Rhône-Alpes. Type: | 41 | 12 | 33 | 31 |
 | Meridiam For people and the planet - delivering transformational infrastructure, for the long term. Meridiam was founded in 2005 by Thierry Déau, with the belief that the alignment of interests between the public and private sector can provide critical solutions to the collective needs of communities. Meridiam is an independent investment Benefit Corporation and an asset manager. The firm specializes in the development, financing, and long-term management of sustainable public infrastructure in three core sectors: sustainable mobility, critical public services and innovative low carbon solutions. With offices in Addis Ababa, Amman, Dakar, Istanbul, Luxembourg, Paris, Vienna, Libreville, Johannesburg and Washington, Meridiam … Type: | 86 | 32 | 58 | 369 |
 | Andera Partners The Power of And Created over 20 years ago, Andera Partners is a major player in private company investments in France and internationally. Its teams manage €4.3 billion in investments in life sciences (Andera Life Sciences), growth and buyout capital (Andera MidCap, Andera Expansion/Croissance, Andera Co-Invest), sponsorless transactions (Andera Acto) and ecological transition (Andera Infra). Andera Partners’ mission is to work alongside companies and their managers to support them in achieving strong and sustainable growth. The quality of performance offered to our investors relies on a strong partnership between the entrepreneurs in our portfolio companies and our teams, based on … Type: | 40 | 25 | 20 | 128 |
 | Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 5 | 2 | 2 | 22 |
 | Mnemo Therapeutics Empower the body, cure the disease Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer. The paucity of actionable cancer-specific targets creates significant challenges in the field of immuno-oncology. To address this, Mnemo has developed a combination of in-silico and wet-lab pipelines to uncover new tumour-specific targets (called E-antigens) derived from the unexploited dark genome, and to develop multiple therapeutic modalities (i.e. cell therapy, TCE, ADC, vaccine) targeting these E-antigens. Mnemo is currently pursuing several discovery campaigns for E-antigens, with a plan to develop its proprietary tumour-specific … Type: | 6 | 5 | 3 | 34 |
 | Talas Partners [Automatic translation follows] The right financing at the right time! Talas Partners is your partner of excellence to propel your company's innovation towards new horizons. Who are we? Much more than a simple consulting firm in innovation financing, we become your partner to achieve your entrepreneurial goals and lead you to success. Our passion is to transform each innovative project into a successful entrepreneurial success. Our Mission We have a clear mission: to help Startups and SMEs develop their business by mobilizing public or private financing. Our Support Present in the innovation ecosystem for a very long time, we guide … Type: | 7 | 2 | 5 | 3 |
 | Noema Pharma Developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS | 1 | 1 | 0 | 31 |
 | Octarine Bio We're harnessing nature to drive sustainable solutions Pioneering new sustainable bio-based ingredients Synthetic Biology, Fermentation, Yeast metabolism, Plant metabolism, and Metabolic engineering Type: | 3 | 2 | 1 | 28 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 5 | 0 | 4 | 17 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 14 |
 | enginzyme Developing technologies to meet the sustainability goals of the future Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the … Type: | 8 | 3 | 6 | 46 |
 | 2CFinance [Automatic translation follows] Independent financial consulting firm, specializing in Transaction Services and Part Time DAF Our mission: "Advise investors and managers to diagnose and improve the quality and performance of corporate financial departments". • Consulting firm, based in Paris 9th, Aix-en-Provence and Nantes. • Two professions: delegated operational financial management and financial consulting. • A team of 50 employees. • More than 500 missions conducted in Small and MidCap companies, respecting absolute discretion and confidentiality. • A portfolio of renowned entrepreneurs, managers and investment funds. • Long experience in supporting companies in different key phases of their development (start-up, growth, … | 67 | 12 | 59 | 102 |
 | mind Health [Automatic translation follows] The strategic information media dedicated to the digital transformation of the healthcare industries. mind Health is a strategic information media that offers daily monitoring of the news in the healthcare sector and weekly in-depth analysis articles enriched by data. Its mission is to decipher the transformations of the healthcare sector and industries through its economic, technological, regulatory and political issues. mind Health is aimed at all players in the value chain in the healthcare ecosystem: pharmaceutical and medical device industries, electronics, IT and telecoms, mutual insurance companies and insurance, public and private healthcare provision, service providers, etc. Type: | 83 | 5 | 81 | 4 |
 | Pixium Vision S.A. Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: | 10 | 7 | 3 | 22 |
 | Cardiologs AI Serving Cardiology Cardiologs is a medical technology company on a mission to democratize expert cardiac care through medical-grade artificial intelligence. Machine Learning, Big Data, MedTech, Cardiology, Artificial Intelligence, ECG analysis, Holter analysis, and SaaS Type: | 19 | 13 | 4 | 74 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 44 | 16 | 31 | 182 |
 | MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 36 | 14 | 31 | 82 |
 | Sensorion Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … Type: | 15 | 9 | 6 | 77 |
 | IRB Barcelona International biomedical #research center devoted to curing #cancer and other diseases linked to #aging. CERCA-BIST. We are a biomedical research centre that works to achieve a society free of diseases. Our research purpose is to address fundamental biological questions in order to decipher why diseases develop and find new ways to diagnose, prevent and treat them. Our Institute holds more than 500 scientists and support staff from 41 nationalities. It is organised around three major research challenges: Cancer Science, Aging and Metabolism, and Mechanisms of Disease. The Institute was created by the Catalan government in 2005 and is located at … Type: | 26 | 9 | 19 | 478 |
 | London TechWatch The most trusted publication focused exclusively on the London Technology ecosystem, startups, and venture. London TechWatch is the destination for startup news; opinions and reviews; investment and product information; events reported, experienced, seen, heard and overheard here in London. Type: | 52 | 1 | 50 | 1 |
 | Abingworth Life Science Investing Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 180 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022. Investing in … Type: | 16 | 4 | 8 | 44 |
![[iito] Life Science](/media/logo/169393.jpeg){kind=logo} | [iito] Life Science Worldwide Mass Spectrometry & Transatlantic Life Science Business News https://t.co/dFBSfg8Zmb, https://t.co/6AvoAqaGQh, https://t.co/znABFjUO2M Type: | 52 | 0 | 52 | N/A |
 | Drug Discovery World The Global Business Review of Drug Discovery and Development Welcome to our LinkedIn page. This is where we will share original content from the DDW team and industry experts, as well as daily news and other company updates. Published for over 20 years, DDW is the only truly global business review of all aspects of drug discovery and development and has firmly established itself as a highly respected and ‘must read’ journal within the discovery and development arena. DDW is renowned for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised ‘platform’ for ‘Industry … Type: | 28 | 3 | 26 | 8 |
 | Présidence de la République [Automatic translation follows] The President of the French Republic embodies the authority of the State. He is the Head of State in France, the head of the armed forces and the guarantor of the Constitution of the Fifth Republic. Since May 14, 2017, the President of the French Republic is Emmanuel Macron. The President has been elected by direct universal suffrage since 1965 for a 5-year term. His role is to ensure the normal functioning of public authorities and the continuity of the State. He is also the guarantor of national independence, territorial integrity and respect for treaties. Type: | 385 | 285 | 41 | 1,526 |
 | ISALT [Automatic translation follows] Financing the new French industry and meeting the challenge of transitions "Our goal is to grow French companies through long-term investment" ISALT is a portfolio management company whose mission is to invest in the long term in the capital of listed or unlisted French companies. Since its creation in 2020, ISALT has set itself the ambition of developing a long-term investment platform with the aim of providing stable and constructive capital to French companies operating in key sectors for our economy. As such, it implements an investment strategy that consists of taking significant and long-term stakes in … Type: | 7 | 5 | 2 | 24 |
 | ELSAN [Automatic translation follows] Acting and innovating for the health of all at the heart of the territories ELSAN, the leading private hospital group in France, now has more than 28,000 employees and 7,500 independent doctors who work in the group's 212 establishments and centers. They treat more than 4.8 million patients per year. Our mission: to offer everyone quality, innovative and humane care. Our purpose: Acting for the health of all, at the heart of the territories. Healthcare establishments Type: | 85 | 22 | 58 | 93 |
 | Pear Bio Patient-centered cancer precision medicine Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient-centric functional precision medicine and drug discovery. Our ultimate goal is to optimally allocate approved treatments to cancer patients who will benefit from them, while creating novel therapies that are purpose-designed for patients who don't respond to available treatments. The platform uses microphysiological systems and 3D computer vision to measure cancer progression over time. Pear Bio cultures patient tumor samples with matched blood into 3D immune-microtumors to test potential treatment options and combinations ex vivo. … Type: | 3 | 1 | 0 | 36 |
 | BioCorteX We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work Type: | 1 | 1 | 0 | 15 |
 | BSMART [Automatic translation follows] The 100% economy channel The 100% economy channel | 217 | 113 | 121 | 177 |
 | Womed This is a women's world Womed is pioneering innovative, safe and effective treatments to free women from challenging uterine pathologies: infertility, uterine bleeding, endometriosis. Type: | 10 | 1 | 1 | 13 |
 | Berkeley Center for Law and Business A focal point for teaching, research and conferences on issues at the intersection of law and business. The Berkeley Center for Law and Business convenes programs and supports research in law and business. We connect scholars, practitioners, and students to address challenges related to capital markets, corporate innovation, and sustainability. In the process, we train the next generation of leaders for the global economy. We aim to be the leading venue for conversations about corporate governance, equity and inclusion, financial fraud, mergers and acquisitions, venture capital, and other important policy issues, consistent with the University of California, Berkeley’s role as … Type: | 25 | 0 | 25 | 16 |
 | SWAP Food Formerly Umiami | The tender, juicy whole filet made from plants. We make delicious, clean-label meat replacements from plants. Our first product, SWAP Filet (SWAP Chicken in the United States) is a thick, whole filet that closely replicates the taste, texture and appearance of chicken using a short list of familiar ingredients. From preparation to performance, SWAP Filet can replace chicken on any menu, enabling chefs to recreate classic recipes for modern times. Originally founded in France in 2020, we rebranded from Umiami to SWAP in 2024 to convey how simple it is for consumers and chefs to swap protein. … Tags: FrenchTech120 FrenchTech2030 Type: | 39 | 21 | 24 | 107 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 10 | 5 | 6 | 7 |
 | Microphyt Fostering a Blue Future ! Created in 2007 near Montpellier-France, Microphyt develops and markets unique microalgae-based bioactives using breakthrough technologies and processes. Developed over 10 years, and endorsed by key customers, partners and investors, these bioactives are addressing the nutraceutical & cosmetic industry sectors. photobioreactor, microalgae, nutrition, biotechnology, Blue Future, nutraceuticals, Made in France, Cosmetics, innovation, better living, patented technology, natural ingredients, and bioactive compounds Type: | 30 | 14 | 14 | 62 |
 | GenSight Biologics Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in … Type: | 16 | 6 | 11 | 36 |
 | May Health We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment. May Health, formerly AblaCare, is developing a modern approach to PCOS. Type: | 3 | 2 | 2 | 24 |
 | Entreprises Occitanie [Automatic translation follows] The region's leading economic magazine. Founded in 1983, Entreprises Occitanie covers regional economic news by highlighting all sectors of activity. Designed by a team of professional journalists and published by Medef 31, this monthly is available in 10 issues, supplemented by the Top Economique Occitanie which lists more than 10,000 decision-makers in the region. Reports, portraits of entrepreneurs and the calendar of major events are regularly published on the web. aeronautics, agri-food, space, innovation, finance, employment / training, health, and building Type: | 67 | 5 | 66 | 7 |
 | Vestbee Empowering founders, VCs, accelerators and corporates with the right community, infrastructure, and tools to succeed. Vestbee is one of the leading platforms empowering startup founders, VC funds, angels, accelerators and corporates with the right community, infrastructure, and tools to succeed. Type: | 65 | 3 | 62 | 13 |
 | Redmile Group Redmile Group is a company based out of San Francisco. Type: | 2 | 2 | 0 | 68 |
 | Jolt Capital Scaling responsible deeptech companies Jolt Capital SAS is a fully independent Private Equity firm authorized and regulated by AMF (Autorité des Marchés Financiers) that specialises in Technology, targeting investments into companies with revenues between €10m and €50m. Jolt Capital generates returns for its investors by enabling mid-sized technology-rich companies with strong fundamentals to execute their growth strategies, in sectors that offer good exit potential across software and hardware alike (cybersecurity, sensors, photonics, industrial processes, new energy systems, applied AI, robotics...) In providing growth capital to our portfolio companies, we support their scaling in new markets, new capacities and new acquisitions, … Type: | 104 | 9 | 100 | 36 |
 | Neoplants The first generation of plants bioengineered to fight air pollution. www.neoplants.com The first plant-microbiome systems bioengineered to purify indoor air. | 15 | 10 | 8 | 37 |
 | AFYREN Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. Our Technology is based on a biomimetic fermentation process patented worldwide through 10 patent families 🔬 Our production model: AFYREN NEOXY, AFYREN’s first plant is a unique, low-carbon, zero-waste biorefinery that produces 7 100% biobased acids. It is located in Carling Saint-Avold (Grand-Est region, France) a strategic location set in … Type: | 85 | 27 | 66 | 119 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 11 | 10 | 1 | 48 |
 | EKTAH [Automatic translation follows] New nutritional solutions to reduce human and animal body weight gain EKTAH's mission is to restore pleasure to each individual in a situation of obesity or overweight, allowing them to reduce their body weight and return to a healthy, tasty and balanced diet without depriving themselves. The company's scientific approach consists of identifying lipid "decoys (or agonists)" capable of activating oro-gustatory receptors more intensely than dietary fatty acids, thus allowing the brain to trigger early satiety, which will immediately lead to a reduction in food intake. These decoys do not provide calories and would also trigger a … | 19 | 7 | 17 | 2 |
 | HighLife Trans-septal Mitral Valve Replacement HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients. | 5 | 2 | 1 | 72 |
 | BrightHeart Advancing prenatal ultrasound screening with AI At BrightHeart, we believe every single fetal ultrasound screening exam should be performed with the highest level of accuracy, so each mother and baby receive the highest possible quality of care. Type: | 2 | 2 | 1 | 10 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models Type: | 8 | 4 | 6 | 26 |
 | EryPharm EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron Type: | 9 | 1 | 8 | 4 |
 | datacraft [Automatic translation follows] The data scientists Club datacraft allows an exchange of best practices between data experts. It is a unique Club model, inspired by mentoring, and designed to allow data scientists/data engineers to train among peers and allow companies to accelerate their AI/data projects Access to the Club is through an annual membership. Type: | 61 | 8 | 48 | 14 |
 | Predict4Health AI-powered Precision Medicine for Organ Failure Our mission is to improve patients’ live and healthcare systems by postponing organ failure with the power of AI. 💪 Our products : 📊 A Decision making tool based on iBox : Predigraft helps physicians monitor transplanted patients by providing allograft survival prognosis. 📱 A Smart telemonitoring of chronic patients : Apilife is a fully connected platform acting as a medical hub for patients and their medical teams. 🧬 A Digital Biomarker for clinical trials : Our technology can be used to design clinical trials and to assess kidney allograft survival. Medicine, Machine Learning, … Type: | 48 | 7 | 36 | 26 |
 | Inotrem Control innate immunity Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock. Founded in 2013, with offices in Paris and a technology center in Nancy (France), the company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide, with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases. Type: | 7 | 6 | 1 | 33 |
 |  Mablink Bioscience Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D Type: | 15 | 9 | 10 | 35 |
 | Micropep Technologies Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins. Type: | 19 | 11 | 6 | 57 |
 | Moon Surgical Empowering the Surgeon Moon Surgical aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics. medical device, minimally invasive surgery, digital surgery, comanipulation, AI, Machine Learning, Surgery, Laparoscopy, and Surgical Robotics Tags: FrenchTech120 FrenchTech2030 Type: | 16 | 8 | 8 | 78 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 17 | 11 | 6 | 126 |
 | CorWave CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up … Tags: FrenchTech120 Type: | 31 | 17 | 23 | 100 |
 | PEAK LIFECYCLES HR - Europe & the US Beyond the people you want, get the people you need PEAK LIFECYCLES HR is an international Executive Search and Talent Management company dedicated to Global "Care environment" markets and their stakeholders. Placing the analysis of the business life cycle, and that of products, skills, and projects at the heart of its activity, Peak Lifecycles' unique, innovative expertise is founded on its anticipation of market requirements. OUR OFFERS: Executive Search, Talent Management, Organizational audit, Executive Coaching We also developed an offer dedicated to Startups and their lifecycles. Executive Search, Talent Management, Life Sciences, Market Access, Medical, Business Operation, Digital , Food, … Type: | 25 | 0 | 23 | 12 |
 | Cure51 We want every patient to become a Cancer Survivor. Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus … Type: | 6 | 4 | 2 | 29 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 11 | 6 | 6 | 34 |
 | Merieux Equity Partners Invested Investors Merieux Equity Partners is a multistage investment manager specialized in the healthcare & nutrition sectors via two dedicated platforms: Venture and Growth/Buyout. As an independent General Partner - registered under the French Financial Markets Authority AMF ("Autorité des Marchés Financiers") - Merieux Equity Partners currently manages 5 main funds, representing more than €1 billion of Commitments, and has supported over 45 companies in Europe and North America since its creation - in Venture Capital and Growth/Buyout. Our passion is to work alongside entrepreneurs and companies with an ambitious growth plan, offering them privileged access to our sector-expertise and … Type: | 11 | 9 | 5 | 38 |
 | Bon Vivant Animal-free dairy proteins, for a sustainable future. We are a French biotechnology company developing cutting-edge precision fermentation techniques, dedicated to take part in the environmental transition within the dairy production sector. Our innovative technology enables the production of dairy proteins without the need for animals, significantly reducing the ecological footprint. By providing our clients with cutting-edge, sustainable ingredients, we empower them to create a diverse range of dairy products identical to those you already love, both environmentally conscious and nutritionally rich. Join us on our journey to shaping a future where ethical dairy alternatives are complementary to conventional farming and … Type: | 52 | 13 | 40 | 111 |
 | GLEAMER Medical-Grade AI for Radiology GLEAMER offers a suite of AI solutions for radiology that encapsulate medical-grade expertise. Our company wants to support imaging readers to secure diagnoses for all patients at all times while improving comfort and workflow efficiency. Our team imagines and develops solutions booth at the level of an expert and is easy to integrate thanks to the joint work of a multi-disciplinary team encapsulating AI and radiologist experts. GLEAMER has already been integrated into more than 2.000 institutions in each part of the world. 🏅Alexander Margulis award - Scientific excellence for the BoneView clinical study 🏅 🏅 … Type: | 24 | 10 | 16 | 84 |
 | Enersens Enersens produces the best thermal barriers and additives to improve safety, energy efficiency and flame protection Enersens is a leading innovative company specializing in silica aerogel products. We develop and market high performance aerogel-based insulation materials. We aim to become the leader in these high performance materials to enable our customers and partners to achieve their own goals around global trends in energy efficiency, sustainability, electric mobility and clean energy. Our Skogar® products solve the thermal runaway problems of batteries for any type of electric vehicle or electric mobility. Their performance and finesse also make it possible to solve many … Type: | 34 | 5 | 32 | 8 |
 | RE:CHEMISTRY - By GFBio We make everyday products safe and sustainable. We aim to end chemical pollution in consumer products. We make everyday products safe and sustainable. We aim to end chemical pollution in consumer products by replacing harmful petro-based ingredients. Levulinic Acid, Application Development, R&D, Green Chemistry, and Formulation Development Type: | 6 | 2 | 3 | 37 |
 | CONCILIO Your key to better care. CONCILIO is revolutionizing healthcare access with its unique MEDICAL CONCIERGE service, which combines cutting-edge technology with a team fully dedicated to the well-being of employees and their families. We support businesses and their employees daily through a wide range of services: doctor recommendations, easy appointment scheduling, teleconsultations, digital health assessments, and preventive programs. Concilio also offers its partners the chance to benefit from its advanced technological expertise through CONCILIO SOLUTIONS. This service enables professionals to innovate, increase profitability, and leverage our proven technologies, teams, and processes. E-santé, Téléconsultation, Recherche de Médecins, Bilan Santé, téléconseil médical, … Type: | 26 | 6 | 19 | 43 |
 | Catsalyze We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze. Type: | 28 | 5 | 24 | 3 |
 | GOURMEY 🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. [join.gourmey.com] GOURMEY is France's pioneering cultivated meat company. 🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. > Join.gourmey.com Type: | 36 | 12 | 30 | 103 |
 | RebrAIn ReBrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated. Type: | 17 | 7 | 8 | 18 |
 | GIMLI Leverage Real World Evidence in oncology Gimli empowers medical professionals to structure medical data. We extract and structure data directly from the EMR to streamline RWD, allowing the generation of strong RWE. Ask us for a demo! Gimli is a Startup working with university hospitals, pharmaceutical companies, data analytics providers, and startups. Type: | 29 | 2 | 11 | 6 |
 | MSInsight Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for … Type: | 36 | 6 | 35 | 8 |
 | Abivax Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. Abivax also plans to initiate a Phase 2a clinical trial of obefazimod in patients with Crohn’s disease. Obefazimod is an investigational, orally administered, once-daily therapy, which we believe has the potential to be a differentiated treatment option for inflammatory bowel diseases. It is the first and only molecule … Type: | 9 | 5 | 5 | 81 |
 | Gradient Denervation Technologies Transforming the treatment of pulmonary hypertension A solution for patients suffering from heart failure with pulmonary hypertension. Type: | 1 | 1 | 0 | 14 |
 | VITAL MEAT Sustainable, healthy and delicious cultivated meat 🌎🍴 VITAL MEAT is a cultivated meat start-up based out of Nantes, France 🇫🇷 Our mission is to reduce human impact on the environment by providing HEALTHY, DELICIOUS, ETHICAL and SUSTAINABLE meat to billions of people 🌎 Thanks to our scalable technology and a cost effective process, we are gearing up to commercialize our first chicken product 🐔! Type: | 15 | 5 | 11 | 12 |
 | PE Cube You're Good, get Better. PE Cube is a SaaS solution for each team member of Private Equity management companies to optimize fund management’s performance and Investor Relation while enabling a rich, reliable and transparent communication towards each of its stakeholders. PE Cube is based on 20 years of Private Equity practice and on the key-belief that data is crucial to each level of fund management. This is why PECube is designed to ensure flawless end-to-end processing to express the full potential for monitoring and steering fund management activity. Each general partner member is thus equipped to ensure reliability, security and … Type: | 44 | 4 | 44 | 13 |
 | Quantum Surgical Standardize minimally invasive cancer treatment Quantum Surgical is a French company founded in Montpellier, France, speacialized in medical robotics and AI. Its Epione® robotic percutaneous ablation platform is dedicated to the curative and early treatment of cancers. Quantum Surgical thus offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better targeted and less invasive treatments. Hundreds of patients have already been treated worldwide. Co-founded in 2017 and with a team of 110+ employees, Quantum Surgical is based in Montpellier, with offices in Miami, Florida. Quantum Surgical received the Prix Galien USA … Tags: FrenchTech2030 Type: | 44 | 13 | 36 | 119 |
 | BionomeeX BionomeeX provides innovative analysis tools to support your biological, medical and environmental R&D projects. BionomeeX is a CNRS, and Univ. Montpellier spin off company. Our solutions include, at the same time, crafted algorithms and/or adapted computational solutions in a single package following your needs and demands. We also deploy our own software initially brewed in the academic world to provide solutions in biology, genetics, genomics... Biology, AI, and DeepLearning Type: | 14 | 1 | 4 | 6 |
 | Le Monde [Automatic translation follows] The leading news, everywhere, all the time, by the editorial staff of Le Monde. LeMonde.fr has been on the Internet since December 19, 1995, 51 years to the day after the creation of the paper newspaper. The site and its mobile applications are among the most consulted in France to follow the news in real time (international, economic, political, social, ...) Leading news website in French. Journalism, Media, Online press, Written press, Internet, Video, and Ethics Type: | 606 | 484 | 145 | 2,801 |
 | La French Care [Automatic translation follows] The Health Actors Movement Our mission? To unite the Health ecosystem. La French Care is the Health Actors Movement, it is supported by Bpifrance and the Acteurs de la French Care association, which brings together private and public actors in the health sector in France. La French Care serves the development of ecosystems and excellence in the service of the patient. La French Care's mission: to promote and develop excellence in health in France. Type: | 35 | 17 | 17 | 7 |
 | Fast Company Inspiring the future of business. Fast Company is the world’s leading business media brand, with an editorial focus on innovation in technology, leadership, world changing ideas, creativity, and design. Written for and about the most progressive business leaders, Fast Company inspires readers to think expansively, lead with purpose, embrace change, and shape the future of business. social media Type: | 182 | 128 | 46 | 3,200 |
 | Purespring Therapeutics We are Purespring. We are on a mission to radically transform the treatment of kidney diseases. Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases. biotechnology, gene therapy, and kidney diseases Type: | 1 | 1 | 1 | 52 |
 | Founders Future Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and digital startups. Founded by the serial European tech entrepreneur, Marc Ménasé, Founders Future is a venture studio, providing creativity, network, support and productive capital. We've built a investment platform dedicated to entrepreneurs and managed by entrepreneurs, bringing high value and an ambitious mindset. We aim to partner with outstanding personalities, to align stakeholder’s interest and to foster operational partnerships. Our mission is to become a sparring-partner and continuously try to impact the business on the product, go-to-market, business development and talent acquisition. We've hired top-notch operating … Type: | 90 | 39 | 69 | 22 |
Public